GlassScriptPhysician profile
Ravi Panjabi
NPI 1225024219
$21,190.05
in general payments reported to CMS, 2019-2025
50 companies · $439 in 2025
The $439 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,728 · 2020: $2,560 · 2021: $1,208 · 2022: $4,533 · 2023: $1,200 · 2024: $2,522 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,689 · Travel and Lodging: $1,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,688.68 |
| Travel and Lodging | $1,472.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $7,065.95 | 2019-2020 | |
| Painteq LLC | $1,766.87 | 2021-2022 | |
| Omnia Medical, LLC | $1,600.00 | 2020 | |
| Abbott Laboratories | $1,471.41 | 2019-2025 | Proclaim, Eterna |
| Surgentec | $1,183.37 | 2022 | |
| Curonix LLC | $893.85 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $830.28 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $785.04 | 2019-2025 | Belbuca |
| Nalu Medical, INC. | $631.76 | 2022-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $629.33 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Medtronic Vascular, INC. | $614.21 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $416.16 | 2019-2023 | Ztlido |
| Vertos Medical, INC. | $384.16 | 2022 | |
| Spr Therapeutics, INC | $383.72 | 2022-2023 | Sprint Pns System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $297.33 | 2019-2025 | Relistor |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Panjabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.